Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatment

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD), also called metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent syndrome marked by liver fat accumulation in the absence of significant alcohol consumption, encompassing simple fatty liver, nonalcoholic steatohepatitis (NASH), and advanced stages such as fibrosis and cirrhosis. Its incidence has surged globally, impacting up to 40% of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alcohol Consumption and Health Effects
• Share to Diet, Metabolism, and Disease
• Share to Liver Disease Diagnosis and Treatment